Latest news
Seres Therapeutics Inc (MCRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:13:05 GMTSeres Therapeutics exits more Cambridge real estate early - The Business JournalsThe Business Journals · Wed, 05 Aug 2026 21:16:00 GMTSeres Therapeutics Q2 Operating Income USD -2 - MoomooMoomoo · Wed, 05 Aug 2026 15:28:36 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:13:24 GMTSeres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocusGuruFocus · Wed, 05 Aug 2026 13:03:49 GMTSeres Therapeutics Q2 Net Income Reaches $4.6 Million - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTSeres Therapeutics reports Q2 2026 net income of $4.6M, cash $15.6M, advances SER-155 clinical plans - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMT